ICD code T63.034S – Taipan venom toxic effect, undetermined, sequela

Key Takeaways

T63.034S is a valid, billable ICD-10-CM leaf code for taipan venom toxic effect, undetermined intent, sequela encounter.

The sequela condition (e.g. neuropathy G62.89) is sequenced FIRST; T63.034S follows as the cause, never as principal diagnosis.

‘Undetermined intent’ requires explicit physician documentation; coders cannot infer it and must default to accidental (T63.031) when the record is silent.

T63.034S already names the agent, intent and encounter, so no separate external cause code is needed. Never pair it with W59.1- codes, which describe nonvenomous snakes.

ICD-10 Code T63.034S: Definition, billability, and code type

ICD-10 Code T63.034S is a valid, billable ICD-10-CM diagnosis code for the toxic effect of taipan venom at a sequela encounter.

It applies where intent could not be determined. The CDC/NCHS ICD-10-CM web tool classifies it as a leaf-level code within Chapter 19 (Injury, Poisoning, and Certain Other Consequences of External Causes). That means it carries all required characters and is valid for claim submission without further extension.

The quick-reference table below captures the core facts coders need before reading further.

Code hierarchy: Where T63.034S sits in ICD-10-CM

Understanding the hierarchy explains why T63.034 (without the 7th character) is non-billable and why T63.033 is a different code entirely. The CMS ICD-10-CM codes page publishes the full tabular list, where this lineage appears as follows.

Good revenue cycle documentation starts with understanding exactly where a code sits in this tree. Submitting T63.034 without the S suffix is the single most common rejection trigger for these encounters.

The T63.034 code family: Encounter types A, D, and S

All three encounter-type variants of T63.034 are billable leaf codes. The 7th character is the only difference, yet it determines whether a claim passes or fails medical necessity review.

Use S only when the original toxic effect has resolved. The patient now presents with a complication arising from that earlier event. If any active envenomation treatment is still underway, D is correct, not S.

Sibling codes: Understanding the four intent variants

T63.034 is one of four intent variants for taipan venom toxic effect. Choosing the wrong intent code is a documentation error, not just a billing one, and payers increasingly query undetermined-intent codes when accidental is more plausible.

Per ICD-10-CM Official Guidelines Section I.C.19.e.5, coders must not assign undetermined intent based on their own inference. When the physician record is silent on intent, accidental (T63.031) is the correct default, not undetermined.

Understanding the 7th character S and when sequela applies

ICD-10-CM Official Guidelines Section I.C.19.a defines the three encounter-type characters for injury and toxic-effect codes. Getting this right at the T63.034S level requires applying the definition precisely.

• A (initial encounter): the patient is receiving active treatment for the envenomation. This includes the emergency visit and any inpatient stay for the acute toxic effect, regardless of which provider is seen.
• D (subsequent encounter): the envenomation is still being managed but the patient is in the healing or recovery phase. Routine follow-up while the original condition persists uses D.
• S (sequela): the original envenomation has resolved. The patient now has a complication or late effect caused by that earlier event. The S suffix is placed on the cause code (T63.034S), and a separate code is reported first to identify the sequela condition itself.

Common sequela presentations from taipan envenomation include peripheral neuropathy (G62.89), chronic renal impairment (N18.x), or coagulopathy-related conditions. Each of those codes is sequenced before T63.034S in the encounter coding. The sequela condition code is the reason for the visit; T63.034S explains why the condition exists.

Clinical scenarios: When T63.034S is the correct code

These scenarios illustrate the conditions under which ICD-10 Code T63.034S applies and where a different encounter type is more appropriate.

• T63.034S applies: A reptile handler presents eight months after a captive taipan bite with progressive peripheral neuropathy. The original bite has healed, but the neurological damage is an ongoing late effect. The physician notes “neuropathy secondary to prior taipan envenomation; original intent undetermined.” Correct codes: G62.89 (peripheral neuropathy, other), then T63.034S.
• T63.034S applies: A patient returns six months post-discharge with chronic kidney disease attributed to venom-induced nephrotoxicity. The acute toxic effect resolved during the initial admission. Physician documents undetermined intent at the original event. Code the CKD stage first, then T63.034S.
• T63.034A applies instead: The same patient presenting to the emergency department on the day of the bite. The envenomation is active and being treated. T63.034S would be wrong here regardless of intent.
• T63.034D applies instead: A follow-up neurology visit three weeks post-bite where ongoing antivenom effects are still being monitored. The original toxic effect has not resolved. D is correct; S is premature.

Documentation requirements for T63.034S

Every element of T63.034S must be supported by physician documentation. Coders cannot construct this code from clinical inference alone. The chart must contain all of the following to support a T63.034S assignment.

• Documented history of prior taipan envenomation: a prior encounter note, discharge summary, or explicit reference to the bite event in the current chart. The sequela code requires a traceable original event.
• Documented sequela condition: the specific late-effect diagnosis (e.g. “peripheral neuropathy attributed to prior taipan envenomation”). The sequela condition, not T63.034S, drives medical necessity for the visit.
• Documented resolution of the acute event: the original toxic effect must have resolved for S to apply. Notes that indicate ongoing active toxicity require D, not S.
• Explicit physician statement that intent was undetermined: phrases like “intent of the original exposure could not be determined” or “circumstances of envenomation unclear” are required. Silence on intent defaults to accidental (T63.031S).

Strong medical billing compliance programs flag sequela encounters for a documentation review checklist before submission. A single missing element, particularly the undetermined-intent statement, is enough for a payer to request medical records or deny the claim outright.

Code sequencing: T63.034S is never the principal diagnosis

ICD-10-CM Official Guidelines Section I.B.10 governs sequela coding. The sequela condition is always sequenced first, followed by the cause code with the S suffix. T63.034S is never the principal diagnosis in a sequela encounter.

An example code sequence for a peripheral neuropathy sequela visit with undetermined-intent taipan bite history:

1. G62.89 – Other specified polyneuropathies (the sequela condition, reason for visit)
2. T63.034S – Toxic effect of taipan venom, undetermined, sequela (the causal code)

No external cause code follows T63.034S. ICD-10-CM Official Guidelines Section I.C.20.a.8 says no Chapter 20 code is needed when another chapter’s code already includes the external cause and intent. T63.034S carries the taipan venom, the undetermined intent and the sequela encounter. Good medical billing workflow includes a sequela sequencing check before finalizing the claim.

External cause codes for T63.034S

T63.034S is a combination code, so it needs no separate external cause code. It already identifies the agent (taipan venom), the intent (undetermined) and the encounter (sequela). ICD-10-CM Official Guidelines Section I.C.20.a.8 states that no Chapter 20 code is needed in that case.

• W59.1- codes: these describe contact with nonvenomous snakes. A taipan is venomous, so W59.11- and W59.12- never apply.
• X20-X29 codes: the WHO ICD-10 block for contact with venomous animals is not part of ICD-10-CM. In US coding, the venomous agent is captured by the T63 code itself.
• Place and activity codes (Y92, Y93): a Y92 place of occurrence code is generally assigned once, at the initial encounter. Y93 activity codes do not apply to sequela, so neither belongs on a T63.034S claim.

Per AAPC ICD-10-CM coding guidance, external cause codes are secondary codes and should never be reported as the principal diagnosis. On a T63.034S claim, the T63 code already does that job.

Payer coverage and reimbursement considerations

T63.034S is billable under Medicare and most commercial plans, but sequela encounters require documented medical necessity, not just a valid code. The Centers for Medicare and Medicaid Services does not issue a specific Local Coverage Determination for taipan envenomation sequela. The condition is too rare in the United States. Medical necessity is evaluated by the associated sequela condition code (the neuropathy, nephropathy, or coagulopathy code sequenced first).

• Medicare: reimburses based on the sequela condition code, not T63.034S itself. The cause code supports the medical record but does not independently trigger payment.
• Commercial payers: may scrutinize undetermined-intent codes more than accidental-intent codes. Some insurers treat undetermined as a proxy for self-harm and route the claim for additional review. Documentation of why intent could not be established reduces this risk.
• Workers’ compensation: envenomation in an occupational context (e.g. a zookeeper bitten by a captive taipan) requires coordination of benefits. A place of occurrence code and activity code are typically required by the WC carrier and the health payer to establish coverage.
• Prior authorization: not typically triggered by T63.034S alone. Procedures for the sequela condition (nerve conduction studies, dialysis, anticoagulation management) may still need it, based on the procedure code rather than the diagnosis code.

Pabau’s claims management software supports coding workflows that reduce the risk of submitting undocumented intent codes. Electronic submission through electronic claims via Claim.MD, Pabau’s clearinghouse partner for US payers, validates codes against active payer edits before the claim leaves the practice. A clean claim submission for a sequela encounter like this includes the sequela condition code first, T63.034S second, and no separate external cause code.

Common claim denials and coding errors for T63.034S

Sequela coding for rare envenomation cases produces a predictable set of denial patterns. Each of the errors below has a specific fix.

• Submitting T63.034 without the 7th character: the non-billable parent code. Payer systems reject this automatically. Always append A, D, or S based on the encounter type.
• Using T63.034A for a sequela visit: the most common error. A coder working from a template that defaults to A will mismatch the encounter type. The sequela visit requires S, and the sequela condition code must appear first on the claim.
• Omitting the sequela condition code: T63.034S cannot stand alone as the sole diagnosis on a sequela encounter. Without an accompanying condition code (the neuropathy, the renal impairment, etc.), a payer has no medical necessity basis for the visit. It will deny the claim or request records.
• Coding undetermined intent without physician documentation: this is not a coding shortcut. If the record does not explicitly state that intent could not be determined, T63.031S (accidental) is required. Using T63.034S without the supporting statement constitutes a documentation error.
• Adding a snake external cause code: reporting W59.12XA (struck by nonvenomous snake) alongside T63.034S contradicts the venomous agent in the T63 code. Guideline I.C.20.a.8 makes a separate external cause code unnecessary here.
• Sequencing T63.034S as principal diagnosis: this contradicts ICD-10-CM Official Guidelines and will trigger a medical necessity query. The sequela condition drives the visit; T63.034S is the causal/supporting code.

Systematic denial management workflows catch most of these errors at the pre-submission coding review stage rather than after a denial is issued. For a reference on how denial codes map to these error patterns, see the medical billing denial codes reference. Revenue cycle teams handling rare envenomation cases benefit from a short pre-submission checklist. The sequela condition code comes first and T63.034S second. The chart confirms the undetermined-intent statement, and no nonvenomous-snake W59 code is attached.

Codes commonly confused with T63.034S

The table below covers the codes coders most frequently select in error when working a taipan sequela case with undetermined intent.

Reduce coding errors and claim denials with Pabau

Pabau’s claims management tools and Claim.MD clearinghouse integration validate ICD-10 codes against payer edits before submission. Sequela encounter errors are caught before they become denials.

Book a demo

Conclusion

T63.034S is a valid, billable code for a clinically specific scenario. The patient presents with a late complication of a taipan envenomation, and the original intent was explicitly undetermined. The errors that generate denials are consistent: wrong encounter type, missing sequela condition code, undocumented intent, a nonvenomous-snake external cause code, and incorrect sequencing. A pre-submission review checklist that catches each of these before the claim leaves the practice eliminates the bulk of T63.034S-related rejections.

Pabau’s integrated claims management software connects directly to the Claim.MD clearinghouse, running payer-specific edits on diagnosis codes before submission. To see how the workflow handles sequela encounters and rare toxic-effect codes, book a demo.

Continue your research

Need guidance on denial management for complex encounter types? Denial management in healthcare covers systematic approaches to reducing payer rejections across all code categories.

Want to understand how clearinghouse submissions work? Claim.MD clearinghouse overview explains how electronic claim validation reduces common coding errors before submission.

Looking for a reference on revenue cycle best practices? What is revenue cycle management outlines the end-to-end process from encounter documentation through payment posting.

Frequently Asked Questions